Literature DB >> 10402956

Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events.

A A de Melker1, A Sonnenberg.   

Abstract

Integrins are a family of transmembrane proteins composed of heterodimers of alpha and beta subunits. With their extracellular domain they bind extracellular matrix proteins or other cell surface molecules, and their cytoplasmic domain binds to cytoskeletal and signaling proteins. Thus, they are in an ideal position to transfer information from the extracellular environment to the interior of the cell and vice versa. For several integrin subunits, alternative splicing of mRNA leads to variations in the sequence of both extracellular and cytoplasmic domains. Many integrin splice variants have specific expression patterns, but for some time, functional differences between these variants were not evident. Recent experiments using transfected cell lines and gene targeting of specific splice variants have contributed significantly to our understanding of the function of these splice variants. The results indicate that alternative splicing is a mechanism to subtly regulate the ligand binding and signaling activity of integrins.

Mesh:

Substances:

Year:  1999        PMID: 10402956     DOI: 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  37 in total

1.  Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit.

Authors:  Shigeyuki Kon; Amha Atakilit; Dean Sheppard
Journal:  Exp Cell Res       Date:  2011-04-16       Impact factor: 3.905

2.  Expression of alpha7beta1 integrin splicing variants during skeletal muscle regeneration.

Authors:  Minna Kääriäinen; Liisa Nissinen; Stephen Kaufman; Arnoud Sonnenberg; Markku Järvinen; Jyrki Heino; Hannu Kalimo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

3.  β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

Authors:  Jianming Liu; Derek J Milner; Marni D Boppart; Robert S Ross; Stephen J Kaufman
Journal:  Hum Mol Genet       Date:  2011-12-16       Impact factor: 6.150

4.  The contribution of cellular mechanotransduction to cardiomyocyte form and function.

Authors:  Sean P Sheehy; Anna Grosberg; Kevin Kit Parker
Journal:  Biomech Model Mechanobiol       Date:  2012-07-07

5.  Cloning the human and mouse MMS19 genes and functional complementation of a yeast mms19 deletion mutant.

Authors:  L Queimado; M Rao; R A Schultz; E V Koonin; L Aravind; T Nardo; M Stefanini; E C Friedberg
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

6.  Differential expression of the integrins alpha6Abeta4 and alpha6Bbeta4 along the crypt-villus axis in the human small intestine.

Authors:  Anders Bondo Dydensborg; Inga C Teller; Nuria Basora; Jean-François Groulx; Joëlle Auclair; Caroline Francoeur; Fabrice Escaffit; Fréderic Paré; Elizabeth Herring; Daniel Ménard; Jean-François Beaulieu
Journal:  Histochem Cell Biol       Date:  2008-12-24       Impact factor: 4.304

Review 7.  Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function.

Authors:  Megan L McCain; Kevin Kit Parker
Journal:  Pflugers Arch       Date:  2011-04-19       Impact factor: 3.657

8.  Integrin α6β4 in colorectal cancer.

Authors:  Jean-François Beaulieu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

Review 9.  Integrins, focal adhesions, and cardiac fibroblasts.

Authors:  Ana Maria Manso; Seok-Min Kang; Robert S Ross
Journal:  J Investig Med       Date:  2009-12       Impact factor: 2.895

10.  Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.

Authors:  Ivan P Gorlov; Jinyoung Byun; Olga Y Gorlova; Ana M Aparicio; Eleni Efstathiou; Christopher J Logothetis
Journal:  BMC Med Genomics       Date:  2009-08-04       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.